|
Regulatory
Obama's Mixed Message on Support for Biopharma R&D
President Obama took center stage last week to unveil his "Precision Medicine Initiative," a $215 million program to build a genomic information database to support future biomedical research. But he is also calling to reduce exclusivity on brand biologics from 12 to 7 years and curb "evergreen" patents on certain biologics ...Read more
The pharma  KAM imperative: it’s not just a role on the sales team, it’s a program of how to work differently with large, organized customers.
Regulatory
20 States May Legislate "Right to Try" in 2015
Expect a wave of states adopting “right to try laws” this year, according to David Farber partner in the FDA & Life Sciences Practice Group at King & Spalding. Some 20 states could have new laws on the books by this time next year, though time will tell what kind of impact they’ll have for patients or drug makers
...Read more
Events
Message from Morgan: The Top Takeaway from This Year's J.P. Morgan Investor Conference
The J.P. Morgan Investor Conference can resemble a predatory feast. Like spawning salmon, drugmakers fattened by great science nudge their forward-looking statements upstream—right into the jaws of grizzly investors. But the big message from this year's event is that, for every start-up salmon caught, dozens more are now making it past the VC bears ...Read more
Leadership
Pharm Exec's 2015 Emerging Pharma Leaders — Nominate Now!
Pharm Exec is looking for the fresh faces of pharma leadership, and we'd like your input! Tell us who you think should be included as one of Pharmaceutical Executive's 2015 Emerging Pharma Leaders. Read more for details of how to nominate a colleague — or yourself. The deadline for this year's entries is April 15
...Read more
Europe
Greece's New Government Sets Out Pharma Plans
Pharma and healthcare are among the many areas being viewed with increasing attention inside and outside Greece, following the victory in the country's elections of the radical left-wing, anti-austerity Syriza party (a victory it secured by forming a coalition with the right-wing Independent Greeks party). And the new government's plans are certainly ambitious ...Read more
Forecast
What's Ahead? Pharm Exec's 2015 Industry Forecast
Following a year where a phenomenal cure was met by pricing outrage, the march of new products and promising immunotherapy cancer combos will continue in 2015. As pharma and tech jell, how will the industry live up to its value supposition while pricing and profiting in the developed and developing worlds? ...Read more
|
